4.6 Letter

Effect of the COVID-19 pandemic on oncology screenings: it is time to change course

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study

O. Meggetto et al.

Summary: The COVID-19 pandemic significantly reduced cervical screening and follow-up services in Ontario, leading to decreased volumes of tests and treatments, highlighting the need for ongoing monitoring and system response.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Oncology

Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era

A. Toss et al.

Summary: The study found that a 2-month interruption in breast cancer screening led to an increase in node-positive and stage III breast cancer patients, particularly among those with high proliferation rates. Despite the screening interruption, procedures to establish a definitive diagnosis and treatment start were not delayed.

ESMO OPEN (2021)

Review Oncology

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Rachel Riera et al.

Summary: The study identified a high frequency of delays and disruptions in cancer care services globally due to the reduction in service availability caused by the COVID-19 pandemic. Various categories of delays and disruptions were found to impact cancer treatment, diagnosis, and general health services.

JCO GLOBAL ONCOLOGY (2021)